Healthcare provider profile · identity verified

Robert D Lehrer, MD

Family Practice · PRIOR LAKE, MN · NPI 1710945209

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	482	151
Lisinopril	Lisinopril	339	99
Losartan Potassium	Losartan Potassium	299	92
Amlodipine Besylate	Amlodipine Besylate	286	90
Rosuvastatin Calcium	Rosuvastatin Calcium	253	78
Simvastatin	Simvastatin	197	56
Levothyroxine Sodium	Levothyroxine Sodium	192	58
Metoprolol Succinate	Metoprolol Succinate	190	57
Metformin Hcl	Metformin Hcl	163	49
Omeprazole	Omeprazole	157	49
Tamsulosin Hcl	Tamsulosin Hcl	133	43
Gabapentin	Gabapentin	128	41
Metformin Hcl Er	Metformin Hcl	106	37
Hydrochlorothiazide	Hydrochlorothiazide	99	36
Pravastatin Sodium	Pravastatin Sodium	96	28
Pantoprazole Sodium	Pantoprazole Sodium	86	26
Albuterol Sulfate Hfa	Albuterol Sulfate	83	32
Eliquis	Apixaban	83	22
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	82	11
Carvedilol	Carvedilol	81	26
Trazodone Hcl	Trazodone Hcl	72	23
Metoprolol Tartrate	Metoprolol Tartrate	71	23
Sertraline Hcl	Sertraline Hcl	69	25
Furosemide	Furosemide	68	27
Jardiance	Empagliflozin	65	20
Glimepiride	Glimepiride	64	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	15
Allopurinol	Allopurinol	57	22
Glipizide Er	Glipizide	56	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	55	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	53	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	14
Finasteride	Finasteride	51	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	15
Oxycodone Hcl	Oxycodone Hcl	50	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	49	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	18
Lorazepam	Lorazepam	49	suppressed
Pregabalin	Pregabalin	49	suppressed
Bupropion Xl	Bupropion Hcl	47	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	suppressed
Prednisone	Prednisone	47	27
Citalopram Hbr	Citalopram Hydrobromide	46	14
Ozempic	Semaglutide	46	11
Venlafaxine Hcl Er	Venlafaxine Hcl	45	12
Duloxetine Hcl	Duloxetine Hcl	44	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	44	13
Fluticasone Propionate	Fluticasone Propionate	42	16
Warfarin Sodium	Warfarin Sodium	42	14
Celecoxib	Celecoxib	41	15
Triamcinolone Acetonide	Triamcinolone Acetonide	41	25
Clopidogrel	Clopidogrel Bisulfate	38	12
Potassium Chloride	Potassium Chloride	38	14
Spironolactone	Spironolactone	38	12
Zolpidem Tartrate	Zolpidem Tartrate	38	12
Lidocaine Hcl Viscous	Lidocaine Hcl	34	suppressed
Famotidine	Famotidine	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Nitroglycerin	Nitroglycerin	30	20
Clonazepam	Clonazepam	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Atenolol	Atenolol	27	11
Jantoven	Warfarin Sodium	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Azithromycin	Azithromycin	16	13
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Irbesartan	Irbesartan	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Testosterone	Testosterone	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Torsemide	Torsemide	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Baclofen	Baclofen	12	suppressed
Buprenorphine	Buprenorphine	12	suppressed
Cimetidine	Cimetidine	12	suppressed
Endocet	Oxycodone Hcl/Acetaminophen	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Digoxin	Digoxin	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Praluent Pen	Alirocumab	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error